ArticleAntonie van Leeuwenhoek2025
The discovery, probiotic properties, and genome analysis of Lactiplantibacillus plantarum HP-B1280 with potential therapeutic application for the treatment of non-alcoholic fatty liver disease.
Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The anti-inflammatory, antioxidant properties of many probiotic microbes and their ability to modulate the composition of intestinal flora suggest that they have the potential to prevent and/or treat nonalcoholic fatty liver disease (NAFLD). The present study provides evidence that Lactiplantibacillus plantarum HP-B1280 can significantly reduce fat accumulation and inflammatory cell infiltration within the hepatocytes of fatty liver mice and thus may have potential application value in the prophylaxis and treatment of NAFLD disease. HP-B1280 also exhibits an extremely high level of resistance to acids and bile salts. The fermentation broth of HP-B1280 cultures is effectively suppresses the growth of a variety of common human pathogens. A comprehensive analysis of the complete genome sequence of L. plantarum HP-B1280 was conducted. Results indicated that the genome of L. plantarum HP-B1280 was devoid of resistance genes, drug resistance genes, as well as virulence factors. The annotation of the genome provides a foundation for further studies on the mechanism underlying the prevention and treatment of NAFLD by L. plantarum HP-B1280. In summary, the findings of the present study provides valuable insights into the potential use of probiotics, such as L. plantarum HP-B1280 in the amelioration and prophylaxis of NAFLD.
Indexed as
Identifiers
41037152What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.